Antidepressant Makers Expected To Testify At Sept. 9 Hearing On Trial Data Disclosure
This article was originally published in The Pink Sheet Daily
Executive Summary
House Commerce/Oversight Subcommittee Vice Chairman Greg Walden will oversee discussion of FDA, industry handling of data on antidepressant-related pediatric suicides.